Pacific Edge surges; NZX 50 falls

Pacific Edge surges; NZX 50 falls
Dan Brunskill
Shares in cancer diagnostic firm Pacific Edge skyrocketed, climbing more than 20% on a deal with a large US insurer, even as the wider share market edged lower.The S&P/NZX 50 Index fell 58.25 points, or 0.5%, to 12,574.35. Within the index, 23 stocks fell, 21 rose, and six were unchanged. Turnover was $203.1 million.Pacific Edge was the best performer by a wide margin. Investors added $100m, or more than a fifth, to the cancer diagnostic firm’s market capitalisation after its Cxbladder test was approved by the biggest healthcare group...

More Markets

Vital board backs Tait takeover
Markets

Vital board backs Tait takeover

Vital’s board has unanimously recommended that shareholders and option holders accept a full takeover offer from Tait Communications, despite their view that it undervalues the company.In May, Vital shares rallied after it disclosed that Tait, a Christchurch-based critical commun...

Listed property firms welcome ‘Investment Boost'
Property

Listed property firms welcome ‘Investment Boost'

The tax policy could translate into millions in extra cash.

Drury’s ASX stag, MetroGlass’s new owner, and more
Markets Small Cap Wrap

Drury’s ASX stag, MetroGlass’s new owner, and more

Rod Drury goes ‘pre-revenue’ again, plus small cap news from NZ.

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Tom Raynel 03 Jul 2025